// App-Quantinova.ai

BSH2020‐PO‐075 : An audit of tumour lysis syndrome prophylaxis in patients with haematological malignancies

Researchers

Presenter

  • A. Cairns

Principal Investigators

  • M. M. Khan

Medical Centers

  • Department of Haematology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Aberdeen, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Renal insufficiency

Biomarkers

  • RNA-binding protein FUS/TLS

Drug/Treatment

  • Allopurinol

  • Rasburicase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved